Deals
At opening session of CHPA’s annual Self-Care Leadership Summit on March 17 in Orlando, it presented Fuad Sawaya its highest honor named for Ivan Combe, an industry pioneer who served on its board from 1958 until 2000.
Avia Pharma has acquired fellow Swedish firm Allderma to add to its offering brands like Hårkontrol, Daxxin and Lactiplus.
Kenvue’s full-year net sales 2.1% dip to $6.38bn came largely on a 2.2% organic sales decline driven by a 2.3% volume decrease but slightly offset by 0.2% foreign currency benefit.
Australian firm has received unsolicited approaches for its topical Pain Away brand and is considering its options.
Singapore's Zuellig Pharma picks up consumer health brands with over 100 years of heritage through deal with Bayer.
Both companies announced that during special meetings on Jan. 29, their shareholders voted nearly unanimous support for Kimberly-Clark’s $48.7bn acquisition proposed in November at $3.50 per share plus 0.14625 share for each Kenvue share.
Wonderbelly reached market in 2022 and has notched nationwide footprint through major retailers over the years, Target stores starting in March 2023, CVS since June 2024 and Walmart since May 2025.
Reckitt can now focus all of its resources on the consumer health and hygiene markets after divesting its home care business to Advent International.
Covestus Holdings will pay £4.3m to acquire UK-based Venture Life’s oral care brands Ultradex and Dentyl.
France, Spain and Belgium among countries where Cooper Consumer Health has launched NRT brand Nicotinell on behalf of Dr Reddy’s.
Cipla has paid Tata Industries around $12.5m for Inzpera Healthsciences to grow its consumer health portfolio.
Karo will take on responsibility for the marketing, distribution and sales of Moberg’s topical onychomycosis treatment, MOB-15, under the Lamisil brand in 19 European countries.
Kenvue share price on downward trend since its highly anticipated spinout from J&J in 2023.
Kenvue’s latest results could be a sign of things to come for other consumer health product businesses launched as spinouts from pharmaceutical giants. Along with its third-quarter results on Nov. 3, Kenvue announces deal to be acquired by Kimberly-Clark.
“Incredible rigor, thoughtfulness and discipline” went into Kleenex tissues, Huggies disposable diapers, and Kotex tampons marketer Kimberly-Clark’s $48.7bn offer for Kenvue, the former J&J consumer health products business on its own for two years.
A rising demand for eco-certified skin care products attracted Archimed to invest in Denmark's DermaPharm, which markets the Avivir and DermaKnowlogy brands.
Smoking cessation brand Nicotinell is now under the ownership of Dr Reddy's in Germany, where the firm is hoping to lay the foundations for future growth in the consumer health market.
Stada is set for new ownership after CapVest agreed to buy a controlling stake from Bain Capital and Cinven. CapVest is pledging to “deploy significant new capital” to advance Stada’s interests, with the German giant’s CEO hinting at “ambitious plans” for the future.
PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.
Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.